Zolpidem Tartrate Tablet, Film Coated
Product Images NDC 80425-0153

4 FDA label images from Advanced Rx Pharmacy Of Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 80425-0153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Zolpidem Tartrate, showing its molecular formula and arrangement, consistent with the active ingredient in the product. The structure depicts characteristic chemical bonds and groups typical for Zolpidem Tartrate.*
FDA Label Image

Label 1 (Lable 1)

Label 1 (Lable 1)
Zolpidem Tartrate 10 mg film-coated tablet packaging label from Advanced Rx Pharmacy of Tennessee, LLC, Nashville, TN. The label includes barcode, storage instructions at 20-25°C, expiration date 11/30/2023, and comparison reference to Ambien. The product is a schedule C-IV prescription drug.*
FDA Label Image

Label 2 (Lable 2)

Label 2 (Lable 2)
Zolpidem Tartrate 10 mg film-coated tablet label from Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions (20°-25°C), a comparison reference to Ambien with its NDC, lot number, and expiration date (11/30/2023). It also displays a barcode and scheduling classification (C-IV).*
FDA Label Image

Label 3 (Label 3)

Label 3 (Label 3)
Packaging label of Zolpidem Tartrate 10 mg film-coated tablets by Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions at 20°-25°C (68°-77°F), comparison with Ambien, NDC 80425-0153, lot number, and expiration date 11/30/2023. The tablets are identified as controlled substance C-IV.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.